DIABETA Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Diabeta, and when can generic versions of Diabeta launch?

Diabeta is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in DIABETA is glyburide. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the glyburide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Diabeta

A generic version of DIABETA was approved as glyburide by TEVA on August 29^th, 1995.

Try a Trial

Summary for DIABETA

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	152
Clinical Trials:	6
Patent Applications:	3,596
Formulation / Manufacturing:	see details
DailyMed Link:	DIABETA at DailyMed

Drug patent expirations by year for DIABETA

Recent Clinical Trials for DIABETA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Kentucky	Phase 1
Ohio State University	Phase 1/Phase 2
Texas Tech University Health Sciences Center, El Paso	Early Phase 1

See all DIABETA clinical trials

US Patents and Regulatory Information for DIABETA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sanofi Aventis Us	DIABETA	glyburide	TABLET;ORAL	017532-001	May 1, 1984	AB2	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sanofi Aventis Us	DIABETA	glyburide	TABLET;ORAL	017532-002	May 1, 1984	AB2	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sanofi Aventis Us	DIABETA	glyburide	TABLET;ORAL	017532-003	May 1, 1984	AB2	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for DIABETA

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	DIABETA	glyburide	TABLET;ORAL	017532-002	May 1, 1984	⤷ Try a Trial	⤷ Try a Trial
Sanofi Aventis Us	DIABETA	glyburide	TABLET;ORAL	017532-002	May 1, 1984	⤷ Try a Trial	⤷ Try a Trial
Sanofi Aventis Us	DIABETA	glyburide	TABLET;ORAL	017532-001	May 1, 1984	⤷ Try a Trial	⤷ Try a Trial
Sanofi Aventis Us	DIABETA	glyburide	TABLET;ORAL	017532-003	May 1, 1984	⤷ Try a Trial	⤷ Try a Trial
Sanofi Aventis Us	DIABETA	glyburide	TABLET;ORAL	017532-001	May 1, 1984	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for DIABETA

See the table below for patents covering DIABETA around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Switzerland	521952	Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen	⤷ Try a Trial
Israel	22259	BENZENESULFONYL-UREAS AND PROCESS FOR THEIR MANUFACTURE	⤷ Try a Trial
African Intellectual Property Organization (OAPI)	2281		⤷ Try a Trial
Iceland	1612		⤷ Try a Trial
Netherlands	6412137		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for DIABETA

Recent Clinical Trials for DIABETA

Make Better Decisions: Try a trial or see plans & pricing